Home
Our Technologies
Our Inventors
Our team
News
About us
Contact us
Select Page
oxborrow_mark_web_1024
by
Gavin Reed
|
Dec 8, 2022
Accelerated development of a potential treatment for cystic fibrosis
22nd October 2021
Natural Killer – licensing a cell therapy
2nd September 2021
Imperial partner Apollo receives £100m to boost medical research at leading unis
17th June 2021
Loading...